Efficacy News and Research

RSS
KRASG12C inhibitor sotorasib shows durable clinical benefits for solid cancers

KRASG12C inhibitor sotorasib shows durable clinical benefits for solid cancers

Adding abemaciclib to hormonal therapy reduces recurrence in patients with HR+ HER2- early breast cancer

Adding abemaciclib to hormonal therapy reduces recurrence in patients with HR+ HER2- early breast cancer

COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro

Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro

Trial shows new first-line treatment option for patients with metastatic kidney cancer

Trial shows new first-line treatment option for patients with metastatic kidney cancer

UM receives $33.4 million for development and clinical trials of opioid vaccines

UM receives $33.4 million for development and clinical trials of opioid vaccines

Scientists identify new drug to prevent SARS-CoV-2 infection consequences

Scientists identify new drug to prevent SARS-CoV-2 infection consequences

Confidence in COVID-19 restrictions leads to good mental health

Confidence in COVID-19 restrictions leads to good mental health

Discovery could help enhance the effectiveness of immunotherapy against melanoma

Discovery could help enhance the effectiveness of immunotherapy against melanoma

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

Study highlights need for scientific, pharmaceutical standards for developing live biotherapeutic products

Study highlights need for scientific, pharmaceutical standards for developing live biotherapeutic products

Scientists investigate how psychedelic drugs interact with brain cells at the molecular level

Scientists investigate how psychedelic drugs interact with brain cells at the molecular level

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Animal data supports efficacy of baricitinib vs SARS-COV-2

Animal data supports efficacy of baricitinib vs SARS-COV-2

International researchers set out to compare different countries' COVID-19 responses

International researchers set out to compare different countries' COVID-19 responses

T cells on the front line of COVID-19 response

T cells on the front line of COVID-19 response

Safer UVC light effectively kills SARS-CoV-2

Safer UVC light effectively kills SARS-CoV-2

New drug candidate suppresses SARS-CoV-2 replication

New drug candidate suppresses SARS-CoV-2 replication

PPI use linked to worse outcomes in urothelial cancer patients treated with atezolizumab

PPI use linked to worse outcomes in urothelial cancer patients treated with atezolizumab

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.